BLCM's logo.
Ticker Symbol: BLCM

Bellicum Pharmaceuticals Inc

$2.04 - 04-12-2024 4 p.m. ET

Exchange: OTC MARKETS Country: US Currency: USD Asset Type: Common Stock CIK:0001358403

Company Profile

bellicum pharmaceuticals, located near the houston medical center, is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders. we are developing next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (hsct) and car t cell therapy. we are dedicated to creating an exceptional work environment and are passionate about working to provide innovative new treatment options that can improve health and save lives.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 2710 Reed Road
CEO: Richard Fair
Tags:
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.15
Change: -$0.05 ( -25.41%)
Days Range: $0.12 - $0.22
Beta: -
52wk. High: $0.59
52wk. Low: $0.12
Ytd. Change -75.41%
50 Day Moving Average: $0.31
200 Day Moving Average: $0.37
Shares Outstanding: 9496298

Valuation

Market Cap: 142.4M
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A